The lab-drawn screening test from New Day Diagnostics is available without a doctor’s order in most states and requires no special prep.
New Day Diagnostics today announced the launch of ColoHealth™, a groundbreaking blood test for colorectal cancer screening is now accessible to adults aged 50+ who are at average risk. This test offers a non-invasive alternative for individuals who are unwilling or unable to undergo traditional screening methods such as colonoscopies or stool-based tests. This physician-mediated test is now available direct-to-consumer in all U.S. states except California and New York.
“ColoHealth™ is redefining what’s possible in colorectal cancer screening by combining clinical rigor with real-world usability. With a sensitivity of 73.3%, specificity of 81.5%, and a negative predictive value of 99.8%, it provides both accuracy and reassurance,” noted Eric Mayer, CEO of New Day Diagnostics. “ColoHealth™ detect nearly twice as many pre-cancers as other colorectal screening blood tests.”
“What truly sets it apart is its ability to drive action—over 99% of individuals who previously refused other screenings completed the ColoHealth™ blood test. That kind of adherence is rare, and it translates to lives saved through earlier detection and intervention,” said Mayer.
ColoHealth™ eliminates many of the common barriers that prevent people from getting screened—there’s no bowel prep, no anesthesia, and no need to take a day off work. It’s a simple blood test that puts patients in control of their health.
A Streamlined, Three-Step Process
- Answer Health Questions: Consumers complete a brief medical questionnaire online to confirm eligibility.
- Order Online: Once approved, the test can be purchased securely at ColoHealthy.com. ColoHealth is currently available on a self-pay basis only.
- Schedule a Blood Draw: Patients select a local lab within New Day’s phlebotomy network and schedule a blood draw at their convenience through an online portal.
If markers for colorectal cancer are detected, a follow-up colonoscopy will be required for diagnostic confirmation.
Colorectal cancer is the second leading cause of cancer-related deaths in the United States. However, screening rates remain low, often due to the invasive nature or inconvenience of traditional procedures. ColoHealth™ aims to increase participation in routine screening by offering a simpler, more accessible option.
To learn more or order the test, visit www.ColoHealthy.com.
Discover the latest trends and insights—explore the Business Insights Journal for up-to-date strategies and industry breakthroughs!
